Literature DB >> 32297980

Failure in initial stage containment of global COVID-19 epicenters.

Veria Khosrawipour1,2, Hien Lau1, Tanja Khosrawipour1,3, Piotr Kocbach4, Hirohito Ichii1, Jacek Bania2, Agata Mikolajczyk5.   

Abstract

With multiple virus epicenters, COVID-19 has been declared a pandemic by the World Health Organization. Consequently, many countries have implemented different policies to manage this crisis including curfew and lockdown. However, the efficacy of individual policies remains unclear with respect to COVID-19 case development. We analyzed available data on COVID-19 cases of eight majorly affected countries, including China, Italy, Iran, Germany, France, Spain, South Korea, and Japan. Growth rates and doubling time of cases were calculated for the first 6 weeks after the initial cases were declared for each respective country and put into context with implemented policies. Although the growth rate of total confirmed COVID-19 cases in China has decreased, those for Japan have remained constant. For European countries, the growth rate of COVID-19 cases considerably increased during the second time interval. Interestingly, the rates for Germany, Spain, and France are the highest measured in the second interval and even surpass the numbers in Italy. Although the initial data in Asian countries are encouraging with respect to case development at the initial stage, the opposite is true for European countries. Based on our data, disease management in the 2 weeks following the first reported cases is of utmost importance.
© 2020 The Authors. Journal of Medical Virology published by Wiley Periodicals Inc.

Entities:  

Keywords:  COVID-19; coronavirus; effective; measures; pandemic; spread

Mesh:

Year:  2020        PMID: 32297980      PMCID: PMC7262316          DOI: 10.1002/jmv.25883

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


INTRODUCTION

The current COVID‐19 outbreak with multiple global epicenters has attracted worldwide attention. Thus, with continuously rising numbers of confirmed cases, COVID‐19 has been declared a pandemic on March 11th, 2020 by Tedros Ghebreyesus, the World Health Organization's (WHO) Director‐General. Current knowledge of the biology and transmission of this virus remains limited , and COVID‐19's final mortality rates are subject to rough estimation. International flight traffic has been majorly affected and many countries report increased COVID‐19 numbers. Significant global COVID‐19 epicenters include Italy, France, Spain, Iran, South Korea, Japan, Germany and the initial place of the outbreak, China. So far, different developments regarding growth rates and case numbers have been observed for each respective country as they pass through the initial stages of the outbreak. Although there are different approaches to attain COVID‐19 containment, the goal of reducing interactions between unidentified infected with noninfected individuals remains unchanged. In a recent study, Wilder‐Smith et al describe these different concepts in detail, ranging from the quarantine of confirmed and possibly infected individuals as implemented in Germany to the declaration of lockdown in Italy, France, and Spain with individual variations. We know from retrospective analysis that travel restrictions can positively impact case development, as observed in past SARS or Ebola outbreaks. , , China's approach in the COVID‐19 outbreak exceeds the classic definition of local confinement, lockdown, and isolation. With increasing implementation of curfew and lockdown measures in Europe, grave concerns in the population are mounting that previous attempts in handling the COVID‐19 spread have been insufficient. , The aim of this study is to evaluate and compare case development, growth rate and doubling time during the initial phase of COVID‐19 exposure for each respective country.

MATERIALS AND METHODS

Data sources

Confirmed cases of COVID‐19

The total number of confirmed COVID‐19 cases for Asia (China, South Korea, and Japan), Europe (Italy, Germany, France, and Spain), and Iran were obtained from the COVID‐19 situation reports made publicly available by the WHO. The present study included data from January 20th, 2020 to March 13th, 2020 as reported by the WHO (see Figure 1).
Figure 1

Cumulative development of COVID‐19 cases in China, South Korea, Japan, Italy, Germany, France, Spain, and Iran according to WHO data. Data for the months of January, February and March and magnification of latest case developments outside of China

Cumulative development of COVID‐19 cases in China, South Korea, Japan, Italy, Germany, France, Spain, and Iran according to WHO data. Data for the months of January, February and March and magnification of latest case developments outside of China

Outcome measures and statistical analysis

The first 6 weeks after initial reports of COVID‐19 cases in Italy, France, Spain, Iran, South Korea, Japan, Germany, and China were subject to analysis. This time span of 6 weeks was divided into two intervals: (a) a first 3‐week interval and (b) a second 3‐week interval. We chose an observation period of 6 weeks as most initial worldwide cases occurred within a 6‐week time span (Figure 1). For these two intervals, we measured the doubling time (d) in days and the corresponding growth rate (g). An exponential growth curve with least squarer regression analysis was estimated for both 3‐week time intervals for each respective each using the following model: C(x) represents the calculated COVID‐19 cases in total numbers at each time point x based on the current cases C and the doubling time d in days. The values for x range from 1 to 21 days according to the length of each 3‐week interval. The approximated doubling time of cases is described by d for each time interval. The growth curves were approximated for each interval (see Figure 2A,B). The corresponding growth rate for the same interval was approximated by:
Figure 2

Cumulative development of COVID‐19 cases in China, South Korea, Japan, Italy, Germany, France, and Spain within the first and second 3‐week intervals. Projections of the calculated exponential growth within both intervals for each respective country

Cumulative development of COVID‐19 cases in China, South Korea, Japan, Italy, Germany, France, and Spain within the first and second 3‐week intervals. Projections of the calculated exponential growth within both intervals for each respective country x and x describe the observed time interval and n the amount of days within the interval. Growth curves of total confirmed COVID‐19 case numbers are graphically demonstrated including their individual 95% confidence interval (CI; see Figure 3).
Figure 3

Growth rates for China, South Korea, Japan, Italy, Germany, France, Spain, and Iran at each time interval (95% CI)

Growth rates for China, South Korea, Japan, Italy, Germany, France, Spain, and Iran at each time interval (95% CI)

RESULTS

Asia

Growth rate of total confirmed COVID‐19 cases during the first and second 3‐week interval

In Asia, the growth rate of total confirmed COVID‐19 cases in China decreased substantially during the second time interval (0.025, 95% CI: 0.017‐0.033) vs the first‐time interval (0.16, 95% CI: 0.14‐0.18) (Figure 3). The opposite relationship was observed in South Korea. In comparison to the first 3‐week period (0.13, 95% CI: 0.11‐0.15), the growth rate of COVID‐19 cases increased remarkably during the second 3‐week period (0.25, 95% CI: 0.23‐0.27; Figure 3). In Japan, the growth rate was similar between the first (0.10, 95% CI: 0.078‐0.13) and second 3‐week interval (0.11, 95% CI: 0.099‐0.11; Figure 3).

Doubling time of total confirmed COVID‐19 cases during the first and second 3‐week interval

In China, the doubling time of total confirmed COVID‐19 cases during the second 3‐week interval (27.66, 95% CI: 20.91‐40.51) was markedly higher than that in the first 3‐week interval (4.31, 95% CI: 3.89‐4.79) (Figure 4). In comparison to the first‐time interval (5.51, 95% CI: 4.69‐6.55), the growth rate of COVID‐19 cases in South Korea during the second time interval (2.78, 95% CI: 2.55‐3.04) was considerably lower (Figure 4). The doubling time of COVID‐19 cases in Japan was similar between the first (6.90, 95% CI: 5.53‐8.85) and second‐time interval (6.54, 95% CI: 6.09‐7.03) (Figure 4).
Figure 4

Doubling time of COVID‐19 cases for China, South Korea, Japan, Italy, Germany, France, Spain, and Iran at each time interval (95% CI)

Doubling time of COVID‐19 cases for China, South Korea, Japan, Italy, Germany, France, Spain, and Iran at each time interval (95% CI)

Europe and Iran

For countries in Europe, the growth rate of COVID‐19 cases increased considerably in the second time interval (Italy: 0.20, 95% CI: 0.19‐0.21; Germany: 0.32, 95% CI: 0.29‐0.34; France: 0.32, 95% CI: 0.29‐0.35; and Spain: 0.36, 95% CI: 0.34‐0.38) compared to the first time interval (Italy: 0.022, 95% CI: 0.014‐0.031; Germany: 0.054, 95% CI: 0.040‐0.070; France: 0.068, 95% CI: 0.054‐0.082; and Spain: 0.042, 95% CI: 0.028‐0.056) (Figure 3). In Iran, the growth rate for COVID‐19 cases was the highest in comparison to other countries during the first 3‐week interval (0.20, 95% CI: 0.18‐0.23) (Figure 3). In European countries, the doubling time decreased substantially during the second 3‐week interval (Italy: 3.40, 95% CI: 3.22‐3.58; Germany: 2.19, 95% CI: 2.02‐2.37; France: 2.17, 95% CI: 1.99‐2.38; and Spain: 1.95, 95% CI: 1.85‐2.06) compared to the first 3‐week interval (Italy: 30.82, 95% CI: 22.41‐48.87; Germany: 12.77, 95% CI: 9.96‐17.38; France: 10.27, 95% CI: 8.46‐12.84; and Spain: 16.60, 95% CI: 12.39‐24.58) (Figure 4). Similar to other countries, the doubling time of COVID‐19 cases in Iran remained low during the first‐time interval (3.42, 95% CI: 3.02‐3.89) (Figure 4).

DISCUSSION

During the initial phase, the rise of COVID‐19 cases differs significantly when comparing the analyzed epicenters. Although especially European countries (Italy, Spain, and Germany) initially detected very few cases in the first 3‐week interval of global COVID‐19 spread, there is a sharp increase in case numbers during the second 3‐week interval. In contrast, Asian countries like Japan and South Korea detected higher case numbers during the first 3‐week interval, with a slight but remarkable decrease during the second 3‐week interval. This observation is further supported when analyzing the data of case growth and doubling time. However, the data for China and Iran is inconclusive. Although according to our data, China seems to have reached a plateau phase, the reliability of the data remains uncertain as China has changed the diagnostic criteria multiple times within a short period of time. Similarly, the data for Iran is probably biased and incomplete for analysis. Our data indicate that the European countries may not have been well prepared to contain the COVID‐19 case spread. Many of the current cases in Europe can be traced back to northern Italy and Iran, the two main COVID‐19 epicenters outside of Eastern Asia. Like China, Iran displayed very low doubling times in the first 3‐week interval. This finding may be a strong indicator that detection of COVID‐19 occurred at later stages with a more large‐scale virus spread. This underreporting and insufficient disease detection is a source of continuous concern. The overall international COVID‐19 case development remains concerning and a significant trend of initial underreporting must be assumed. This is a negative development and indicates the possibility of further COVID‐19 spread, especially as most countries still report very few initial cases. As many counties are at different stages of the COVID‐19 epidemic, the question arises as to how reinfection can be avoided once curfew and lockdown measures are lifted. Our data support the effectiveness of current containment and testing efforts. However, short‐time curfew might not be an alternative to long‐term containment and testing measures. The concept of wave patterns has been previously described for other pandemic outbreaks. These waves can be experienced for many months. , , Limitations of this study include the quality of provided case numbers, as they might be subject to bias and underreporting. It remains challenging to distinguish the effect of different measures due to a lack of testing kits, insufficient detection, and varying containment policies. The extent of overall testing seems to correlate with the awareness of serious health risks in the observed countries. As official case numbers have increased with the onset of containment measures, one can assume that testing is itself part of the containment strategy. , In fact, evaluation of individual strategies is not possible as only the totality of combined effects and policies of each country regarding quarantine, regional lockdowns, travel restriction, testing, and social distancing can be evaluated. This problem has already been recognized in the evaluation of single containment measures. , With respect to these considerations, this study focuses on the combination of all measures taken by a country to evaluate the quality of the initial response to this outbreak.

CONCLUSION

Following the analysis of different European and Asian countries heavily affected by COVID‐19, our data indicate significant differences in initial growth rates and doubling time. According to our data, European countries seem to have missed effective measures to contain COVID‐19 at the beginning of the crisis compared to their counterparts in Asia. This is further substantiated by continuously, rapidly increasing COVID‐19 case numbers in European countries, which call for more draconic containment measures.

CONFLICT OF INTERESTS

The authors declare that there are no conflict of interests.

AUTHOR CONTRIBUTIONS

VK: data acquisition, data interpretation, final analysis, drafting of the manuscript, final approval for publication. HL: data acquisition, analysis, and interpretation, drafting of the manuscript, final approval for publication. TK, PK, and HI: data interpretation, drafting of the manuscript, final approval for publication. JB and AM: data interpretation, conception, and design of the work, critical revision for important intellectual content, final approval for publication.
  17 in total

1.  Inferring the causes of the three waves of the 1918 influenza pandemic in England and Wales.

Authors:  Daihai He; Jonathan Dushoff; Troy Day; Junling Ma; David J D Earn
Journal:  Proc Biol Sci       Date:  2013-09-07       Impact factor: 5.349

2.  A review of the 1918 herald pandemic wave: importance for contemporary pandemic response strategies.

Authors:  Lone Simonsen; Gerardo Chowell; Viggo Andreasen; Robert Gaffey; John Barry; Don Olson; Cécile Viboud
Journal:  Ann Epidemiol       Date:  2018-03-02       Impact factor: 3.797

3.  COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation.

Authors:  Marcel Salathé; Christian L Althaus; Richard Neher; Silvia Stringhini; Emma Hodcroft; Jacques Fellay; Marcel Zwahlen; Gabriela Senti; Manuel Battegay; Annelies Wilder-Smith; Isabella Eckerle; Matthias Egger; Nicola Low
Journal:  Swiss Med Wkly       Date:  2020-03-19       Impact factor: 2.193

4.  The effect of travel restrictions on the spread of a moderately contagious disease.

Authors:  Martin Camitz; Fredrik Liljeros
Journal:  BMC Med       Date:  2006-12-14       Impact factor: 8.775

5.  Population mobility reductions associated with travel restrictions during the Ebola epidemic in Sierra Leone: use of mobile phone data.

Authors:  Corey M Peak; Amy Wesolowski; Elisabeth Zu Erbach-Schoenberg; Andrew J Tatem; Erik Wetter; Xin Lu; Daniel Power; Elaine Weidman-Grunewald; Sergio Ramos; Simon Moritz; Caroline O Buckee; Linus Bengtsson
Journal:  Int J Epidemiol       Date:  2018-10-01       Impact factor: 7.196

6.  The positive impact of lockdown in Wuhan on containing the COVID-19 outbreak in China.

Authors:  Hien Lau; Veria Khosrawipour; Piotr Kocbach; Agata Mikolajczyk; Justyna Schubert; Jacek Bania; Tanja Khosrawipour
Journal:  J Travel Med       Date:  2020-05-18       Impact factor: 8.490

7.  Preliminary estimation of the novel coronavirus disease (COVID-19) cases in Iran: A modelling analysis based on overseas cases and air travel data.

Authors:  Zian Zhuang; Shi Zhao; Qianying Lin; Peihua Cao; Yijun Lou; Lin Yang; Daihai He
Journal:  Int J Infect Dis       Date:  2020-04-14       Impact factor: 3.623

8.  Effective containment explains subexponential growth in recent confirmed COVID-19 cases in China.

Authors:  Benjamin F Maier; Dirk Brockmann
Journal:  Science       Date:  2020-04-08       Impact factor: 47.728

9.  Internationally lost COVID-19 cases.

Authors:  Hien Lau; Veria Khosrawipour; Piotr Kocbach; Agata Mikolajczyk; Hirohito Ichii; Justyna Schubert; Jacek Bania; Tanja Khosrawipour
Journal:  J Microbiol Immunol Infect       Date:  2020-03-14       Impact factor: 4.399

Review 10.  Can we contain the COVID-19 outbreak with the same measures as for SARS?

Authors:  Annelies Wilder-Smith; Calvin J Chiew; Vernon J Lee
Journal:  Lancet Infect Dis       Date:  2020-03-05       Impact factor: 25.071

View more
  23 in total

1.  Serological study of healthcare workers in four different hospitals in Madrid (Spain) with no previous history of COVID-19.

Authors:  Fabián Vázquez Rivas; Sandra Nieto Schwarz; Jaime Villarreal Carreño; Ámbar Deschamps Perdomo; Ghino Patricio Villanueva; Mayra Garrafa; M Teresa Del Campo
Journal:  Occup Environ Med       Date:  2021-05-26       Impact factor: 4.402

2.  Impact of COVID-19 Pandemic and Pattern of Patient Care in Otorhinolaryngology Practice in a Tertiary Referral Centre.

Authors:  Kalpana Sharma; Abhilasha Goswami; S M Sarun
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-01-08

3.  An oppositional-Cauchy based GSK evolutionary algorithm with a novel deep ensemble reinforcement learning strategy for COVID-19 diagnosis.

Authors:  Seyed Mohammad Jafar Jalali; Milad Ahmadian; Sajad Ahmadian; Abbas Khosravi; Mamoun Alazab; Saeid Nahavandi
Journal:  Appl Soft Comput       Date:  2021-07-10       Impact factor: 6.725

4.  Understanding the possible origin and genotyping of the first Bangladeshi SARS-CoV-2 strain.

Authors:  A S M Rubayet Ul Alam; M Rafiul Islam; M Shaminur Rahman; Ovinu Kibria Islam; M Anwar Hossain
Journal:  J Med Virol       Date:  2020-09-28       Impact factor: 20.693

5.  SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?

Authors:  Lubna Pinky; Hana M Dobrovolny
Journal:  J Med Virol       Date:  2020-06-19       Impact factor: 20.693

6.  Outpatient Otolaryngology in the Era of COVID-19: A Data-Driven Analysis of Practice Patterns.

Authors:  David A Kasle; Sina J Torabi; Emily L Savoca; Benjamin L Judson; R Peter Manes
Journal:  Otolaryngol Head Neck Surg       Date:  2020-05-12       Impact factor: 3.497

7.  Benin responds to covid-19: sanitary cordon without generalized containment or lockdown?

Authors:  Issideen Ayinla Osseni
Journal:  Trop Med Health       Date:  2020-06-15

8.  Why such excess of mortality for COVID-19 in Spain?

Authors:  Vicente Soriano; Pablo Barreiro
Journal:  Ther Adv Infect Dis       Date:  2020-06-04

9.  Underutilization of the Emergency Department During the COVID-19 Pandemic.

Authors:  Anthony D Lucero; Andre Lee; Jenny Hyun; Carol Lee; Chadi Kahwaji; Gregg Miller; Michael Neeki; Joshua Tamayo-Sarver; Luhong Pan
Journal:  West J Emerg Med       Date:  2020-09-24

10.  Failure in initial stage containment of global COVID-19 epicenters.

Authors:  Veria Khosrawipour; Hien Lau; Tanja Khosrawipour; Piotr Kocbach; Hirohito Ichii; Jacek Bania; Agata Mikolajczyk
Journal:  J Med Virol       Date:  2020-04-28       Impact factor: 20.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.